CardioDx Lands $57,491,448 New Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=83a50975-04fd-4770-a72c-db547a89d254&Preview=1 - Date
3/7/2011 - Company Name
CardioDx - Mailing Address
2500 Faber Place Palo Alto, CA 94303 - Company Description
Founded in 2004, CardioDx is a cardiovascular genomic diagnostics company located in Palo Alto, CA. CardioDx develops clinically validated genomic tests to aid in assessing and tailoring care of individuals with cardiovascular disease, including coronary artery disease (CAD), cardiac arrhythmias, and heart failure. - Website
http://www.cardiodx.com - Transaction Type
Venture Equity - Transaction Amount
$57,491,448 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Transaction amount assumes the exercise of warrants of $3,359,837. - M&A Terms
- Venture Investor
Longitude Capital Management - Venture Investor
Undisclosed
